-
Something wrong with this record ?
The association between radiographic progression, functional impairment, markers of dyslipidaemia and inflammation in patients with hand osteoarthritis: a five-year longitudinal study
J. Baloun, X. Švec, LA. Cerezo, O. Růžičková, O. Šléglová, J. Gatterová, M. Tomčík, J. Vencovský, K. Pavelka, L. Šenolt
Language English Country Italy
Document type Journal Article
- MeSH
- Biomarkers * blood MeSH
- Time Factors MeSH
- Dyslipidemias * blood diagnostic imaging MeSH
- Functional Status MeSH
- Hand Joints * diagnostic imaging MeSH
- Blood Sedimentation MeSH
- Middle Aged MeSH
- Humans MeSH
- Longitudinal Studies MeSH
- Inflammation Mediators blood MeSH
- Osteoarthritis * diagnostic imaging blood MeSH
- Disability Evaluation MeSH
- Predictive Value of Tests MeSH
- Disease Progression * MeSH
- Radiography MeSH
- Aged MeSH
- Severity of Illness Index MeSH
- Inflammation blood diagnostic imaging MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
OBJECTIVES: This study aimed to investigate the associations between radiographic damage, serum biomarkers, and clinical assessments in Czech patients with hand osteoarthritis (HOA) over a five-year follow-up period. METHODS: The study cohort comprised 129 patients diagnosed with HOA, including 72 patients with an erosive subtype and 57 patients with a non-erosive subtype. Radiographs were evaluated using the Kallman scoring system by two independent readers. Blood samples were analysed for markers of dyslipidaemia, bone metabolism, and inflammation. Clinical assessments focused on symptom severity and functional impairment. We employed generalised additive modelling (GAM) to analyse the associations between the Kallman score, serum biomarkers and clinical outcomes. RESULTS: The Kallman score was consistently higher in the erosive subtype compared to the non-erosive subtype across all time points and demonstrated a positive correlation with age in both groups. We demonstrated significant positive associations between radiographic progression and erythrocyte sedimentation rate across both HOA subtypes. Additionally, positive associations with the number of swollen joints and health assessment questionnaire scores were observed in all HOA patients, particularly in those with non-erosive subtypes. In contrast, markers of dyslipidaemia (e.g. LDL‐c or atherogenic index) were negatively associated with radiographic progression. No biomarker reliably differentiated between the erosive and non-erosive subtypes. CONCLUSIONS: Our longitudinal study revealed a significant association between systemic/local inflammation, dyslipidaemia, functional impairment and structural progression in HOA. However, these findings warrant further validation through additional studies to confirm these associations.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009689
- 003
- CZ-PrNML
- 005
- 20250429134537.0
- 007
- ta
- 008
- 250415s2025 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.55563/clinexprheumatol/9b9fnm $2 doi
- 035 __
- $a (PubMed)39808271
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Baloun, Jiří $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 245 14
- $a The association between radiographic progression, functional impairment, markers of dyslipidaemia and inflammation in patients with hand osteoarthritis: a five-year longitudinal study / $c J. Baloun, X. Švec, LA. Cerezo, O. Růžičková, O. Šléglová, J. Gatterová, M. Tomčík, J. Vencovský, K. Pavelka, L. Šenolt
- 520 9_
- $a OBJECTIVES: This study aimed to investigate the associations between radiographic damage, serum biomarkers, and clinical assessments in Czech patients with hand osteoarthritis (HOA) over a five-year follow-up period. METHODS: The study cohort comprised 129 patients diagnosed with HOA, including 72 patients with an erosive subtype and 57 patients with a non-erosive subtype. Radiographs were evaluated using the Kallman scoring system by two independent readers. Blood samples were analysed for markers of dyslipidaemia, bone metabolism, and inflammation. Clinical assessments focused on symptom severity and functional impairment. We employed generalised additive modelling (GAM) to analyse the associations between the Kallman score, serum biomarkers and clinical outcomes. RESULTS: The Kallman score was consistently higher in the erosive subtype compared to the non-erosive subtype across all time points and demonstrated a positive correlation with age in both groups. We demonstrated significant positive associations between radiographic progression and erythrocyte sedimentation rate across both HOA subtypes. Additionally, positive associations with the number of swollen joints and health assessment questionnaire scores were observed in all HOA patients, particularly in those with non-erosive subtypes. In contrast, markers of dyslipidaemia (e.g. LDL‐c or atherogenic index) were negatively associated with radiographic progression. No biomarker reliably differentiated between the erosive and non-erosive subtypes. CONCLUSIONS: Our longitudinal study revealed a significant association between systemic/local inflammation, dyslipidaemia, functional impairment and structural progression in HOA. However, these findings warrant further validation through additional studies to confirm these associations.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a progrese nemoci $7 D018450
- 650 12
- $a osteoartróza $x diagnostické zobrazování $x krev $7 D010003
- 650 12
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a longitudinální studie $7 D008137
- 650 12
- $a dyslipidemie $x krev $x diagnostické zobrazování $7 D050171
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a klouby ruky $x diagnostické zobrazování $7 D050823
- 650 _2
- $a zánět $x krev $x diagnostické zobrazování $7 D007249
- 650 _2
- $a radiografie $7 D011859
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a mediátory zánětu $x krev $7 D018836
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a funkční status $7 D000085542
- 650 _2
- $a posuzování pracovní neschopnosti $7 D004185
- 650 _2
- $a krevní sedimentace $7 D001799
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Švec, Xiao $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Cerezo, Lucie Andrés $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Růžičková, Olga $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Šléglová, Olga $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Gatterová, Jindřiška $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Tomčík, Michal $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Vencovský, Jiří $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Pavelka, Karel $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Šenolt, Ladislav $u Institute of Rheumatology, and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. senolt@revma.cz
- 773 0_
- $w MED00001116 $t Clinical and experimental rheumatology $x 0392-856X $g Roč. 43, č. 3 (2025), s. 486-496
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39808271 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134533 $b ABA008
- 999 __
- $a ok $b bmc $g 2311206 $s 1246770
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 43 $c 3 $d 486-496 $e 20250110 $i 0392-856X $m Clinical and experimental rheumatology $n Clin Exp Rheumatol $x MED00001116
- LZP __
- $a Pubmed-20250415